Comments on the efficacy of deferiprone in replacing desferrioxamine for the treatment of iron-overload disease. Mention of a study in this issue by Lisa Anderson and colleagues which reports on the effects of deferiprone and desferrioxamine on hepatic and myocardial concentrations of iron and left-ventricular function; Commentary on iron chelation therapy.
No Comments.